Illumina names Hologic’s MacMillan chair

Illumina Inc. (NASDAQ:ILMN) appointed Stephen MacMillan as chair, succeeding John Thompson who failed to win re-election at the company’s annual meeting amid a proxy battle with activist investor Carl Icahn. MacMillan is CEO of Hologic Inc. (NASDAQ:HOLX). Also joining the board is Scott Ullem, corporate VP and CFO of Edwards Lifesciences Corp. (NYSE:EW).

Yun Yen is relinquishing his CEO role at OBI Pharma Inc. (TPEx:4174) to Heidi Wang while remaining chairman. Wang joins from Bristol Myers Squibb Co. (NYSE:BMY) where she worked for almost 30 years, most recently as VP, head of global regulatory sciences oncology...